GASTROS Study

International @NIHRresearch-funded study to standardise the reporting of critically important outcomes in surgical trials for gastric cancer. #StomachCancer

[GASTROS Study @GASTROSStudy]

'A core outcome set for surgical trials in gastric cancer' is the culmination of 5 years of collaboration between international patients and healthcare professionals. This work is just the start of our journey to improve research quality in this field.

https://t.co/rh3tLrOwZR

[Bilal Alkhaffaf @BilalAlkhaffaf]

https://t.co/Pi9266849H

Our recent @BJSurgery leading article highlights the ongoing issues with outcome reporting in surgical oncology trials, and details our next study aimed at tackling these challenges.

[GASTROS Study @GASTROSStudy]

An important part of our dissemination strategy is to ensure patients can access the research which they participate in. @CR_UK have produced a plain language summary for the @GASTROSStudy that we encourage our partners to share. @OPA_UK @COMETinitiative

https://t.co/aIPtKZG3Cj

[GASTROS Study @GASTROSStudy]

Our latest publication explores how outcomes are prioritised by stakeholders in different regions. This is another important methodological consideration when recruiting stakeholders to a Delphi survey for COS development.

@COMETinitiative

https://t.co/IFM74YoDZV

[BJS @BJSurgery]

In October's BJS:Core outcome set for surgical trials in gastric cancer (GASTROS study): international patient & healthcare professional consensus https://t.co/q6iXNk1ATd @AmyLightnerMD @bplwijn @des_winter @ksoreide @MalinASund @evanscolorectal @nfmkok @robhinchliffe1 @young_bjs

[Martyn Stott @mstotty88]

Final results of @GASTROSStudy by @BilalAlkhaffaf

[GASTROS Study @GASTROSStudy]

https://t.co/WyC4ro60Zk

A final summary of the findings from the GASTROS study including an introduction to work which has already begun to identify outcome measurement instruments and streamline core outcome set development.

@COMETinitiative @NCAresearchNHS @UoM_DCS

[GASTROS Study @GASTROSStudy]

@GastricCancerFD @StomachCancer_ @NoStomach4Cancr @COMETinitiative @FBMH_UoM @SSATNews @JCOG_stomach @ECSCproject @tentaclestudy @StomachCancerCa @GCRegistry @EwenGriffiths @SSGisbertz

[GASTROS Study @GASTROSStudy]

'A core outcome set for surgical trials in gastric cancer' is the culmination of 5 years of collaboration between international patients and healthcare professionals. This work is just the start of our journey to improve research quality in this field.

https://t.co/rh3tLrOwZR

[GASTROS Study @GASTROSStudy]

We have already started work to identify outcome measurement instruments to accompany the core outcome set, as well as develop areas that require further refinement in the future. @Augishealth @NCAresearchNHS @NIHRresearch @IGCCHouston @CanadianGastric @ogsurgery @mygutfeelingca

[GASTROS Study @GASTROSStudy]

The latest publication from @GASTROSStudy details our approach to internationalising core outcome set development. It highlights the magnitude of 'behind-the-scenes' work by a network of collaborators across 6 continents needed to deliver this study.

https://t.co/0oCPHCLj3r

[COMET @COMETinitiative]

One week to go until the final COMET 2020 webinar, where Jamlick Karumbi and @BilalAlkhaffaf will be giving talks on LMIC participation in COS development and reflecting on approaches used for increasing international participation. Register here: https://t.co/BZ9Veudycp

[GASTROS Study @GASTROSStudy]

Congratulations to our CI @BilalAlkhaffaf on the successful defense of his PhD thesis: 'The Development of a Core Outcome Set for Surgical Trials in Gastric Cancer'.

#outcomes #gastriccancer #stomachcancer #NIHRresearch https://t.co/nfRQssJkfG

[GASTROS Study @GASTROSStudy]

There is great uncertainty about the management of esophageal and gastric cancer during the COVID-19 pandemic.

We have teamed up with @OGAAudit and others to gather the views and current practice of surgeons during this time.

https://t.co/ZYKOWzAw6Y

Please share widely.

[GASTROS Study @GASTROSStudy]

A special thank you to all who attended the consensus meeting in Manchester or took part online. 43 patients, nurses and surgeons finalised a core outcome set for surgical trials in gastric cancer.

👏👏👏👏👏👏👏👏

Look out for the list of outcomes soon!

[GASTROS Study @GASTROSStudy]

Less than 90 minutes to go till the start of our consensus meeting in Manchester.

Join us online at https://t.co/Fd5gQuLqGS

[GASTROS Study @GASTROSStudy]

On Sunday 8th March the @GASTROSStudy consensus meeting in Manchester, UK will finalise a core outcome set for surgical trials in gastric cancer.

80 patients, surgeons and nurses have registered to take part at the venue or online.

Look out for our updates!

[GASTROS Study @GASTROSStudy]

We are pleased to confirm that the upcoming consensus meeting on Sunday the 8th of March will be broadcast live online for those wishing to participate but who are unable to attend in person. Patients, nurses and surgeons can register for the meeting at https://t.co/fXQFOhHavf.

[GASTROS Study @GASTROSStudy]

Latest publication from GASTROS.

Patient priorities are not reflected in surgical trials for gastric cancer. This can be changed through the development of a core outcome set relevant to both patient stakeholders and healthcare professionals.

https://t.co/0Ae4sSD1l0

[GASTROS Study @GASTROSStudy]

We are also exploring the possibility of 'virtual online' meeting participation for those who are unable to attend the venue in person. You can register your free ticket for virtual participation at https://t.co/CzwvWlXfkR.

@OPA_UK @COMETinitiative @NCAresearchNHS

[GASTROS Study @GASTROSStudy]

We are pleased to announce the final consensus meeting for the GASTROS study will take place on Sunday the 8th of March 2020 in Manchester, UK.

If you took part in the international Delphi survey and wish to attend, please register your free ticket at https://t.co/CzwvWlXfkR.

[GASTROS Study @GASTROSStudy]

The consensus meeting will consider the results of the international Delphi survey before making a final recommendation of which outcomes to report as a minimum in future surgical trials for gastric cancer.

Places are limited to 15 tickets each for patients, nurses and surgeons.